Provera and hepatic function abnormal Patient Reports February 11, 2012

Provera Side Effects Report #5062912-8
Provera side effect was reported by a Pharmacist from JAPAN on July 11, 2006. Female patient, 57 years of age, was diagnosed with menometrorrhagia and was treated with Provera. After drug was administered, patient experienced the following side effects: hepatic function abnormal, urticaria. Provera dosage: 2.5 MG (2.5 MG,DAILY), ORAL. During the same period patient was treated with PREMARIN, BERIZYM. Patient was hospitalized. Patient recovered.

Provera Side Effects Report #5072442-5
Provera side effect was reported by a Pharmacist from JAPAN on July 20, 2006. Female patient, 57 years of age, was diagnosed with menometrorrhagia and was treated with Provera. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Provera dosage: 2.5 MG (2.5 MG, DAILY), ORAL. During the same period patient was treated with PREMARIN, BERIZYM. Patient was hospitalized. Patient recovered.

Provera Side Effects Report #5106254-0
Provera side effect was reported by a Pharmacist from JAPAN on Aug 31, 2006. Female patient, 57 years of age, was diagnosed with menometrorrhagia and was treated with Provera. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Provera dosage: 2.5 MG (2.5 MG, DAILY), ORAL. During the same period patient was treated with PREMARIN, BERIZYM. Patient was hospitalized. Patient recovered.

Provera Side Effects Report #5118561-6
Provera side effect was reported by a Pharmacist from JAPAN on Sept 15, 2006. Female patient, 57 years of age, was diagnosed with menometrorrhagia and was treated with Provera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Provera dosage: 2.5 MG (2.5 MG, DAILY), ORAL. During the same period patient was treated with PREMARIN, BERIZYM. Patient was hospitalized. Patient recovered.